secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001437749-23-005405
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene enters $25M equity purchase agreement with Lincoln Park Capital
---------------------------------------------------------------------

- Lincoln Park commits to buy up to $25M of CLNN common stock over 36 months at company's discretion.
- Company issued 332,668 initial commitment shares as fee; additional commitment shares possible.
- Regular purchases limited to 75,000 shares per day (up to 200,000 if stock price above $4.00).
- Purchase price at 97% of VWAP; proceeds for clinical development of CNM-Au8 and general corporate.
- Issuance capped at 19.99% of outstanding without stockholder approval unless average price above $1.2404.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923005405/0001437749-23-005405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923005405/clnn20230222_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-005405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer